Company intelligence / Profile preview

Epax

Ålesund, Møre og Romsdal, Norwayepax.com ↗

Ownership: Private
Employees: ~57
Development stage: Commercial

Overview

Epax has a long history of innovation in marine-derived omega fatty acids. It produces ultra-pure EPA/DHA concentrates and novel marine lipids like cetoleic acid. Its products are used globally in nutraceuticals and as pharmaceutical intermediates. Recent clinical trials show benefits for skin redness reduction; animal studies suggest anti-inflammatory and metabolic effects. The company continues to invest heavily in R&D to expand its product range beyond traditional omega‑3s into next-generation marine oils targeting additional health areas.

Therapeutic areas: Metabolic DisordersImmunologyDermatologyCardiovascularNeurology
Modalities: Small moleculeBiologicNutraceutical ingredient
Industry: Contract Manufacturing Organization

Partnerships

Previously acquired by Trygg Pharma—a joint venture of Aker BioMarine ASA & Lindsay Goldberg LLC; now part of Pelagia AS group.

Beyond the preview

Go deeper on Epax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epax.

Explore the full profile